3.10
price up icon1.64%   0.05
after-market Dopo l'orario di chiusura: 3.10
loading
Precedente Chiudi:
$3.05
Aprire:
$3.04
Volume 24 ore:
14,758
Relative Volume:
0.18
Capitalizzazione di mercato:
$137.24M
Reddito:
$18.11M
Utile/perdita netta:
$-18.95M
Rapporto P/E:
-3.5942
EPS:
-0.8625
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+40.27%
6M Prestazione:
+28.63%
1 anno Prestazione:
+129.63%
Intervallo 1D:
Value
$2.93
$3.11
Intervallo di 1 settimana:
Value
$2.60
$3.15
Portata 52W:
Value
$1.31
$4.38

Adagene Inc Adr Stock (ADAG) Company Profile

Name
Nome
Adagene Inc Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
174
Name
Cinguettio
Name
Prossima data di guadagno
2024-03-28
Name
Ultimi documenti SEC
Name
ADAG's Discussions on Twitter

Adagene Inc Adr Stock (ADAG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-06-25 Iniziato China Renaissance Buy
2021-03-08 Iniziato Goldman Buy
2021-03-08 Iniziato Jefferies Buy
2021-03-08 Iniziato Morgan Stanley Overweight

Adagene Inc Adr Borsa (ADAG) Ultime notizie

pulisher
Oct 27, 2024

Short Interest in Adagene Inc. (NASDAQ:ADAG) Declines By 30.7% - MarketBeat

Oct 27, 2024
pulisher
Oct 11, 2024

Adagene Inc. (NASDAQ:ADAG) Short Interest Update - MarketBeat

Oct 11, 2024
pulisher
Oct 09, 2024

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Adagene Announces Upcoming Poster Presentations on Masked - GlobeNewswire

Oct 09, 2024
pulisher
Sep 28, 2024

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year? - MSN

Sep 28, 2024
pulisher
Sep 20, 2024

HC Wainwright Analysts Lift Earnings Estimates for Adagene Inc. (NASDAQ:ADAG) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Adagene Inc. to Post FY2024 Earnings of ($0.78) Per Share, HC Wainwright Forecasts (NASDAQ:ADAG) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Adagene stock holds Buy rating as ESMO data reinforces drug potential in MSS-CRC - Investing.com

Sep 20, 2024
pulisher
Sep 19, 2024

Adagene (NASDAQ:ADAG) Receives Buy Rating from HC Wainwright - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Adagene stock holds Buy rating as ESMO data reinforces drug potential in MSS-CRC By Investing.com - Investing.com South Africa

Sep 19, 2024
pulisher
Sep 18, 2024

HC Wainwright Reiterates "Buy" Rating for Adagene (NASDAQ:ADAG) - MarketBeat

Sep 18, 2024
pulisher
Sep 16, 2024

Adagene reports promising cancer therapy results - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorect - StockTitan

Sep 16, 2024
pulisher
Sep 11, 2024

Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance

Sep 11, 2024
pulisher
Aug 29, 2024

Adagene to Participate in Investor Conferences in September - GlobeNewswire

Aug 29, 2024
pulisher
Aug 29, 2024

Adagene to Participate in Investor Conferences in September, Business Wires News - AsiaOne

Aug 29, 2024
pulisher
Aug 28, 2024

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? - MSN

Aug 28, 2024
pulisher
Aug 28, 2024

Adagene Inc. (NASDAQ:ADAG) Short Interest Up 170.8% in August - Defense World

Aug 28, 2024
pulisher
Aug 21, 2024

Liquidia (NASDAQ:LQDA) vs. Adagene (NASDAQ:ADAG) Critical Contrast - Defense World

Aug 21, 2024
pulisher
Aug 14, 2024

Adagene Inc. (NASDAQ:ADAG) Short Interest Down 34.2% in July - MarketBeat

Aug 14, 2024
pulisher
Aug 09, 2024

Is MannKind (MNKD) Stock Outpacing Its Medical Peers This Year? - MSN

Aug 09, 2024
pulisher
Jul 26, 2024

Short Interest in Adagene Inc. (NASDAQ:ADAG) Decreases By 62.9% - Defense World

Jul 26, 2024
pulisher
Jul 26, 2024

Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update - GlobeNewswire

Jul 26, 2024
pulisher
Jul 23, 2024

Head-To-Head Survey: Altimmune (NASDAQ:ALT) vs. Adagene (NASDAQ:ADAG) - Defense World

Jul 23, 2024
pulisher
Jul 22, 2024

Adagene (NASDAQ:ADAG) Rating Reiterated by HC Wainwright - MarketBeat

Jul 22, 2024
pulisher
Jul 13, 2024

Adagene Inc. (NASDAQ:ADAG) Short Interest Up 45.9% in June - Defense World

Jul 13, 2024
pulisher
Jul 12, 2024

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 - GlobeNewswire

Jul 12, 2024
pulisher
Jul 12, 2024

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September - Yahoo Finance

Jul 12, 2024
pulisher
Jul 08, 2024

Adagene To Participate In The SVB Leerink 11th Annual Global Healthcare Conference - Barchart

Jul 08, 2024
pulisher
Jul 07, 2024

Spruce Biosciences (NASDAQ:SPRB) and Adagene (NASDAQ:ADAG) Financial Contrast - Defense World

Jul 07, 2024
pulisher
Jul 02, 2024

Adagene Reports Full Year 2021 Financial Results and Provides Corporate Update - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Announces Updates to its Board of Directors - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Announces Authorization of Share Repurchase Program up to US$10 Million - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene to Participate in the SVB Leerink 11th Annual Global Healthcare Conference - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Presents Data Demonstrating First and Best-in-Class Potential for Differentiated Preclinical Antibody Candidates at American Association for Cancer Research (AACR) Annual Meeting 2022 - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Announces SAFEbody® Multi-Target Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody ... - Quantisnow

Jul 02, 2024
pulisher
Jul 02, 2024

Adagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody® Novel Masked Antibody-Drug Conjugate - Quantisnow

Jul 02, 2024
pulisher
Jun 29, 2024

Adagene (NASDAQ:ADAG) Given Buy Rating at HC Wainwright - Defense World

Jun 29, 2024
pulisher
Jun 28, 2024

Adagene's (ADAG) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Jun 28, 2024
pulisher
Jun 27, 2024

Adagene Inc. (NASDAQ:ADAG) Sees Large Increase in Short Interest - MarketBeat

Jun 27, 2024
pulisher
Jun 13, 2024

Adagene Inc. (NASDAQ:ADAG) Short Interest Down 75.7% in May - MarketBeat

Jun 13, 2024
pulisher
Jun 13, 2024

Adagene Inc. (NASDAQ:ADAG) Sees Large Drop in Short Interest - Defense World

Jun 13, 2024
pulisher
May 31, 2024

Financial Analysis: Adagene Inc ADR (ADAG)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex

May 31, 2024
pulisher
May 30, 2024

Short Interest in Adagene Inc. (NASDAQ:ADAG) Decreases By 26.5% - MarketBeat

May 30, 2024
pulisher
May 30, 2024

Adagene Inc. (NASDAQ:ADAG) Sees Significant Decrease in Short Interest - Defense World

May 30, 2024
pulisher
May 29, 2024

Comparing Adagene (NASDAQ:ADAG) and Galera Therapeutics (NASDAQ:GRTX) - Defense World

May 29, 2024
pulisher
May 22, 2024

Adagene to Present at Investor Conferences in June - GlobeNewswire

May 22, 2024
pulisher
May 16, 2024

Short Interest in Adagene Inc. (NASDAQ:ADAG) Expands By 6.3% - MarketBeat

May 16, 2024

Adagene Inc Adr Azioni (ADAG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):